Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat Mesilate in COVID-19
NCT04321096Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Apr 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Aarhus University. Started Apr 2020; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04321096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321096.